AAAAAA

   
Results: 1-7 |
Results: 7
DOXORUBICIN PLUS TUMOR-NECROSIS-FACTOR-ALPHA COMBINATION TREATMENTS IN EL4-LYMPHOMA-BEARING C57BL 6 MICE/
Authors: EHRKE MJ VERSTOVSEK S UJHAZY P MEER JM EPPOLITO C MACCUBBIN DL MIHICH E
Citation: Mj. Ehrke et al., DOXORUBICIN PLUS TUMOR-NECROSIS-FACTOR-ALPHA COMBINATION TREATMENTS IN EL4-LYMPHOMA-BEARING C57BL 6 MICE/, Cancer immunology and immunotherapy, 45(6), 1998, pp. 287-298
THYMIC ANTITUMOR EFFECTORS IN MICE CURED OF LYMPHOMA BY CYCLOPHOSPHAMIDE PLUS TNF-ALPHA THERAPY - PHENOTYPIC AND FUNCTIONAL-CHARACTERIZATION UP TO 20 MONTHS AFTER INITIAL TUMOR INOCULATION
Authors: EHRKE MJ VERSTOVSEK S POCCHIARI SK KRAWCZYK CM UJHAZY P ZALESKIS G MACCUBBIN DL MEER JM MIHICH E
Citation: Mj. Ehrke et al., THYMIC ANTITUMOR EFFECTORS IN MICE CURED OF LYMPHOMA BY CYCLOPHOSPHAMIDE PLUS TNF-ALPHA THERAPY - PHENOTYPIC AND FUNCTIONAL-CHARACTERIZATION UP TO 20 MONTHS AFTER INITIAL TUMOR INOCULATION, International journal of cancer, 76(4), 1998, pp. 579-586
SPECIFIC ANTI-EL4-LYMPHOMA IMMUNITY IN MICE CURED 2 YEARS EARLIER WITH DOXORUBICIN AND INTERLEUKIN-2
Authors: EHRKE MJ VERSTOVSEK S ZALESKIS G HO RLX UJHAZY P MACCUBBIN DL MIHICH E
Citation: Mj. Ehrke et al., SPECIFIC ANTI-EL4-LYMPHOMA IMMUNITY IN MICE CURED 2 YEARS EARLIER WITH DOXORUBICIN AND INTERLEUKIN-2, Cancer immunology and immunotherapy, 42(4), 1996, pp. 221-230
MURINE SPLENIC MACROPHAGE TUMORICIDAL ACTIVATION BY CYTOKINES
Authors: VERSTOVSEK S EPPOLITO C UJHAZY P MACCUBBIN DL EHRKE MJ MIHICH E
Citation: S. Verstovsek et al., MURINE SPLENIC MACROPHAGE TUMORICIDAL ACTIVATION BY CYTOKINES, Experimental hematology, 23(6), 1995, pp. 519-528
CYCLOPHOSPHAMIDE PLUS TUMOR-NECROSIS-FACTOR-ALPHA CHEMOIMMUNOTHERAPY CURED MICE - LIFELONG IMMUNITY AND REJECTION OF RE-IMPLANTED PRIMARY LYMPHOMA
Authors: EHRKE MJ VERSTOVSEK S KRAWCZYK CM UJHAZY P ZALESKIS G MACCUBBIN DL MIHICH E
Citation: Mj. Ehrke et al., CYCLOPHOSPHAMIDE PLUS TUMOR-NECROSIS-FACTOR-ALPHA CHEMOIMMUNOTHERAPY CURED MICE - LIFELONG IMMUNITY AND REJECTION OF RE-IMPLANTED PRIMARY LYMPHOMA, International journal of cancer, 63(3), 1995, pp. 463-471
LIPOPOLYSACCHARIDE AND SPLENIC TUMORICIDAL MACROPHAGE ACTIVATION
Authors: VERSTOVSEK S ZALESKIS G MACCUBBIN DL MIHICH E EHRKE MJ
Citation: S. Verstovsek et al., LIPOPOLYSACCHARIDE AND SPLENIC TUMORICIDAL MACROPHAGE ACTIVATION, Journal of leukocyte biology, 56(6), 1994, pp. 714-722
IMMUNOLOGICAL RESPONSES CRITICAL TO THE THERAPEUTIC EFFECTS OF ADRIAMYCIN PLUS INTERLEUKIN-2 IN C57BL 6 MICE BEARING SYNGENEIC EL4 LYMPHOMA/
Authors: HO RLX MACCUBBIN DL UJHAZY P ZALESKIS G EPPOLITO C MIHICH E EHRKE MJ
Citation: Rlx. Ho et al., IMMUNOLOGICAL RESPONSES CRITICAL TO THE THERAPEUTIC EFFECTS OF ADRIAMYCIN PLUS INTERLEUKIN-2 IN C57BL 6 MICE BEARING SYNGENEIC EL4 LYMPHOMA/, Oncology research, 5(9), 1993, pp. 363-372
Risultati: 1-7 |